ORAGENICS, INC. Increase (Decrease) in Income Taxes Receivable
ORAGENICS, INC. (OGEN) reported Increase (Decrease) in Income Taxes Receivable of -$362.22 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2013-03-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2013-03-26
- ORAGENICS, INC. increase (decrease) in income taxes receivable for the quarter ending 2011-12-31 was $0.00.
- ORAGENICS, INC. increase (decrease) in income taxes receivable for the quarter ending 2011-09-30 was $0.00.
- ORAGENICS, INC. increase (decrease) in income taxes receivable for the quarter ending 2011-06-30 was $0.00.
- ORAGENICS, INC. increase (decrease) in income taxes receivable for the quarter ending 2011-03-31 was -$362.22K.
- ORAGENICS, INC. increase (decrease) in income taxes receivable for fiscal 2011 was -$362.22K, a 200.00% decline from fiscal 2010.
- ORAGENICS, INC. increase (decrease) in income taxes receivable for fiscal 2010 was $362.22K.
| Period end | Increase (Decrease) in Income Taxes Receivable 3 month | Increase (Decrease) in Income Taxes Receivable 6 month | Increase (Decrease) in Income Taxes Receivable 9 month | Increase (Decrease) in Income Taxes Receivable 12 month |
|---|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-26 | $0.00 derived: sum of 2 quarters · filed 2013-03-26 | $0.00 derived: sum of 3 quarters · filed 2013-03-26 | -$362.22K 10-K · filed 2013-03-26 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $0.00 derived: sum of 2 quarters · filed 2012-11-14 | -$362.22K 10-Q · filed 2012-11-14 | |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | -$362.22K 10-Q · filed 2012-08-10 | ||
| 2011-03-31 | -$362.22K 10-Q · filed 2012-05-15 | |||
| 2010-12-31 | $362.22K 10-K · filed 2012-04-16 | |||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |